These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28641290)

  • 1. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment.
    Giacomelli G; Finocchio L; Biagini I; Sodi A; Murro V; Introini U; Varano M; Bandello F; Menchini U
    Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
    Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
    Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
    Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
    Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study.
    Rosina C; Romano M; Cigada M; de Polo L; Staurenghi G; Bottoni F
    Eur J Ophthalmol; 2015; 25(1):47-50. PubMed ID: 25044143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study.
    Iacono P; Battaglia Parodi M; La Spina C; Bandello F
    Am J Ophthalmol; 2016 May; 165():174-8. PubMed ID: 27013066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.
    El Matri L; Kort F; Bouraoui R; Karim B; Chebil A; Chaker N
    Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab.
    Ladaique M; Dirani A; Ambresin A
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):542-7. PubMed ID: 25902117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Lee JH; Lee SC; Kim SH; Koh HJ; Kim SS; Byeon SH; Lee CS
    Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
    Teixeira A; Mattos T; Velletri R; Teixeira R; Freire J; Moares N; Bonomo PP
    Ophthalmic Surg Lasers Imaging; 2010; 41(5):546-9. PubMed ID: 20795575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks.
    Mimoun G; Tilleul J; Leys A; Coscas G; Soubrane G; Souied EH
    Am J Ophthalmol; 2010 Nov; 150(5):692-700.e1. PubMed ID: 20719301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSEUDOXANTHOMA ELASTICUM: SUCCESSFUL LONG-TERM MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS WITH PRO RE NATA INTRAVITREAL BEVACIZUMAB INJECTIONS.
    Kim J; Dalziel D
    Retin Cases Brief Rep; 2021 May; 15(3):246-250. PubMed ID: 30048402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks.
    Sekfali R; Mimoun G; Cohen SY; Querques G; Bandello F; Sacconi R; Souied EH; Capuano V
    Eur J Ophthalmol; 2020 May; 30(3):550-556. PubMed ID: 30880436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal Bevacizumab for Choroidal Neovascularization Associated with Angioid Streaks: Long-term Results.
    Lekha T; Prasad HN; Sarwate RN; Patel M; Karthikeyan S
    Middle East Afr J Ophthalmol; 2017; 24(3):136-142. PubMed ID: 29279654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANE DUE TO ANGIOID STREAKS.
    Alagöz C; Alagöz N; Özkaya A; Çelik U; Turan MF; Yazici AT; Çekiç O; Demirok A
    Retina; 2015 Oct; 35(10):2001-10. PubMed ID: 25996427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
    Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks.
    Battaglia Parodi M; Iacono P; La Spina C; Berchicci L; Scotti F; Leys A; Introini U; Bandello F
    Am J Ophthalmol; 2014 Feb; 157(2):374-377.e2. PubMed ID: 24211865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
    Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y
    Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of CNV in angioid streaks by intravitreal use of specific anti-VEGF165 Aptamer (pegaptanib sodium): long-term results.
    Cekiç O; Göçmez E; Kocabora MS
    Curr Eye Res; 2011 May; 36(5):492-5. PubMed ID: 21501082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor.
    Roy R; Saurabh K; Bansal A; Kumar A; Majumdar AK; Paul SS
    Indian J Ophthalmol; 2017 Apr; 65(4):295-300. PubMed ID: 28513493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum.
    Battaglia Parodi M; Romano F; Marchese A; Arrigo A; Llorenç V; Cicinelli MV; Bandello F; Adán A
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):273-278. PubMed ID: 30470876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.